rainmakers.studioMass Tort LeadsMass Tort vs. Class Action
Strategic guide

Mass Tort vs. Class Action Leads: Why One Supports Paid Acquisition and One Doesn’t

14 min read · Updated April 2025 · 2,200 words · 3 decision tests
3
tests that determine viability
90
days — maximum CPR payment window
3–4
years — typical class action wait
67x
return at $3K CPR vs $200K case
Operator Note
Last October an attorney called us about a class action. He had a theory: Google had been inflating ad prices across legal verticals for years. He believed hundreds of thousands of law firms had been overcharged. He wanted to aggregate plaintiffs.

He asked if we could run paid acquisition for it.

We told him we couldn’t help. Not because the case wasn’t real. Because the economics don’t support paid media.

“The case could take three or four years to settle,” he said, framing it as a positive. Long timeline means a big case. Big case means big fees.

We asked him one question: what can you pay per plaintiff today?

He went quiet.

That silence is the entire difference between mass torts and class actions.

It’s not about the merits of the case. It’s about whether the law firm can pay for claimant acquisition on a timeline that makes paid media viable.

Most can’t. Not for class actions.

Here’s why — and why mass torts are a completely different business.

01

The One Question That Determines Everything

Before a law firm can sustain paid claimant acquisition, it has to answer one question:

What can you pay per signed retainer, and how fast can you pay it?

Not “what will each case eventually be worth.” Not “what’s the total MDL settlement likely to be.” What can you pay per signed retainer within 30, 60, or 90 days of delivery.

That number determines whether paid media makes economic sense. Everything else is interesting but irrelevant.

For class actions, the answer is usually nothing — or close to it. The firm is paying acquisition costs today against fees that won’t exist for years. No law firm has the balance sheet to sustain $500 per lead at volume when settlement is 36 months away. The math requires either enormous capital reserves or a willingness to operate at a loss that most firms don’t have.

For mass torts, the answer is different. The litigation has a defined process. MDL proceedings move through discovery, bellwether trials, and settlement on a timeline firms can model. More importantly, firms know roughly what each plaintiff is worth to them. That knowledge lets them set a CPL or CPA they can afford — and pay it on a cycle that actually works.

Weekly. Monthly. Sometimes with partial upfront. The payment structure is negotiable because the economics are predictable.

That is the only distinction that matters operationally. Not which case is more interesting. Not which category sounds more impressive. Which one can the firm pay for today — on terms that allow a lead generation operation to sustain itself.

Mass torts can. Class actions almost never can.

02

What Class Actions Actually Are — And Why They Break the Paid Model

A class action lawsuit is a legal mechanism where a large group of plaintiffs with similar claims against the same defendant litigate collectively. One case. One outcome. Shared recovery.

The economics for paid claimant acquisition look like this:

The firm signs plaintiffs today. The case moves through class certification, discovery, potential appeals, and eventually either a settlement or verdict. That process takes 2-5 years in most cases. During that entire period, the firm earns nothing from those cases. They carry the overhead. They manage the plaintiffs. They fund the litigation.

Then — if the case settles — they receive contingency fees from a pool that has to be divided among potentially thousands or tens of thousands of plaintiffs. Individual recoveries in class actions are often modest. Attorney fees follow accordingly.

A firm that paid $500 per plaintiff at the start of that process needs to model whether the eventual fee — divided by 2-5 years of wait time and thousands of plaintiffs — justifies that acquisition cost. Most models don’t close.

This is why the primary acquisition method for class actions is not paid media. It’s legal referral networks, existing client relationships, community outreach, and plaintiff law firm co-counsel arrangements. The acquisition cost is mostly time, not money. That’s the right model for a category where the cash flow is deferred.

Cold outreach for class action plaintiffs through paid channels also creates a trust problem. Asking someone cold to join a lawsuit against a company they’ve used — without the credibility of a referral or a known legal brand — reads as scammy. The conversion rates on cold paid traffic for class action participation are poor even when the law firm has a strong case.

Class actions are interesting. They are not scalable with paid media unless the firm has unusual capital access and patience.

03

What Mass Torts Actually Are — And Why They Work

A mass tort is a legal mechanism where many plaintiffs with similar claims against the same defendant litigate individually — often consolidated in a Multi-District Litigation (MDL) — but each maintains their own case with their own damages.

The economics look completely different.

Each plaintiff’s case has individual value. A qualifying Roundup plaintiff — documented non-Hodgkin’s lymphoma, multi-year glyphosate exposure — has a case worth $100,000 to $500,000+ on its own. The firm does not have to divide that recovery among thousands of co-plaintiffs.

The litigation timeline is more defined. MDL proceedings have formal structure. Bellwether trials establish case values. Settlement negotiations happen against a known liability picture. Firms can model what a qualifying plaintiff is worth with meaningful accuracy — not perfectly, but well enough to set an acquisition budget.

This is why mass torts support paid claimant acquisition in a way class actions cannot. The firm knows roughly what a qualifying AFFF plaintiff with a bladder cancer diagnosis is worth. They know what they can afford to pay per signed retainer. That number drives the CPL they can pay a lead vendor — and they can pay it on a 30-60 day cycle rather than waiting years for the case to settle.

One operator in our network was spending $500 per day on mass tort claimant acquisition across several active dockets. The economics closed every month because the payment structure between the operator and the law firms matched the litigation timeline.

That’s not possible in class actions. The infrastructure for recurring paid acquisition simply doesn’t exist when fees are 3-4 years away.

FactorClass ActionMass Tort
Payment timeline2–5 years post-settlement30–90 days per retainer
Individual plaintiff valueShared pool — modest per plaintiffIndependent case — $100K–$500K+
Firm can model plaintiff valueRarelyYes — MDL bellwether data
Supports paid acquisitionNoYes — CPL/CPA sustainable
Acquisition methodReferral networks, co-counselPaid media — Meta, Google
Cash flow riskExtreme — years of carryManageable — predictable cycle
04

The Three Tests: Mass Tort vs. Class Action

Before any law firm evaluates paid claimant acquisition for a legal campaign, run these three tests. If a category fails any of them, it’s a class action dynamic regardless of what it’s called. If it passes all three, it’s mass tort eligible.

01
Test 1: Can the firm pay per retainer within 90 days?

Not eventually. Within 90 days of a signed retainer. If the answer is no — if the firm needs to wait for settlement to fund acquisition — paid media doesn’t work. Move to referral networks.

If the answer is yes — even partially — paid acquisition becomes viable. Some mass tort buyers structure payment as a partial advance at retainer plus a success fee at settlement. That hybrid model is what makes the cash flow work.

02
Test 2: Does each plaintiff have independent case value?

In a class action, individual recoveries are modest because the settlement pool is divided. In a mass tort, each plaintiff’s case is evaluated on its own damages. A mesothelioma plaintiff is not sharing their settlement with 10,000 other plaintiffs. Their case value is discrete and significant.

Independent case value is what lets a firm set a CPL that makes sense. When a qualifying plaintiff is worth $200,000 in fees and the CPR for a qualified lead is $3,000 — that’s a 67x return. The math closes with room to spare.

03
Test 3: Can the firm model plaintiff value with reasonable accuracy?

Mass tort firms know what bellwether trial outcomes look like. They know the MDL’s settlement posture. They know roughly what a qualifying plaintiff with a specific diagnosis history is worth.

That knowledge lets them budget. If a firm cannot model plaintiff value — if the eventual outcome is too uncertain to project — they cannot set a sustainable CPL. That uncertainty characterizes class actions more than mass torts.

Decision Framework
Three-for-three on these tests: the category supports paid claimant acquisition.

Zero-for-three: it’s a referral play.
05

Why This Distinction Is the First Question to Ask

Every few months a law firm calls us excited about a new legal category. New legislation. New defendant. New exposure pathway. They want to know if we can generate plaintiffs.

The first question we ask is not “how big is the case?” It’s: what can you pay per signed retainer within 60 days?

If the answer closes — if the economics work on a timeline that allows sustained paid acquisition — we’re interested. If the answer requires waiting for settlement, we refer them to legal referral networks who run on that model.

Most firms waste months trying to run paid claimant acquisition for campaigns where the economics structurally don’t work. They spend $30,000 in lead spend, can’t sustain the cash flow, shut down the campaign, and conclude that paid mass tort acquisition doesn’t work.

It works. But only in the right categories. And only when the payment structure between the firm and the lead source is matched to the litigation timeline.

The difference between mass torts and class actions is not a legal distinction. It’s a cash flow distinction. And cash flow is what determines whether any paid acquisition model survives long enough to produce results.

06

Frequently Asked Questions

Rarely. The exception is a class action with a short expected timeline, strong likelihood of early settlement, and a firm with unusual capital access willing to carry acquisition costs for 12–18 months. These exist. They’re uncommon. Most class action paid acquisition attempts fail because the payment timeline doesn’t match the lead generation cost structure. If a class action firm says they want to run paid acquisition, the first question to ask is: what’s your expected time to settlement, and can you pay per retainer at retainer — not at settlement?
Three factors. First, the MDL must be active — not closed, not pre-certification, not speculative. Active MDL with established case values means the firm can model what a plaintiff is worth and set a sustainable CPL. Second, the qualifying criteria must be specific enough to generate a defined plaintiff population. Vague exposure categories produce low disqualification rates on the form and high disqualification rates at intake. Third, there must be active buyer demand — law firms writing checks for qualified plaintiffs today, not hoping to buy plaintiffs later if the case develops favorably. All three present: the campaign is worth entering.
The fastest test is the individual damages question. In a mass tort, each plaintiff has their own case with individual damages evaluated on their specific exposure, diagnosis, and circumstances. In a class action, the settlement is a pool divided among all plaintiffs. If a $500 million settlement divided by 100,000 plaintiffs means each plaintiff gets $5,000 and the attorney fee is $1,500 per plaintiff — that’s a class action structure. If a plaintiff’s mesothelioma diagnosis produces a case worth $800,000 independently — that’s mass tort structure. Individual damages = mass tort. Shared pool = class action.
Some do. The math requires either significant capital reserves to carry months of lead spend at volume, or a very short time-to-settlement. Most firms don’t have the balance sheet to sustain $50,000–$100,000 per month in acquisition spend for 2–4 years against deferred fees. The firms that have tried have generally either run out of capital before the case settled or found that the eventual fees didn’t justify the accumulated acquisition cost. There are exceptions — firms with litigation finance arrangements or credit facilities specifically for claimant acquisition. But those are specialized financing situations, not the default.
Legal referral networks. Co-counsel arrangements with firms that have existing plaintiff relationships. Community outreach through organizations relevant to the plaintiff class. PR and earned media that generates inbound awareness. Settlement monitoring services that identify potential plaintiffs through public records. These approaches have lower direct cost because the acquisition expense is primarily time and relationship capital rather than ad spend — which is appropriate for a category where the cash flow to pay for leads doesn’t exist until settlement.

The firms that figure this out early spend their acquisition budget on categories where the economics close. The firms that don’t spend it learning the hard way that not every legal category that looks interesting on paper is viable for paid acquisition.

Mass torts are the category where it works. Class actions are where firms go to learn why it doesn’t.

Mass Tort. Not Class Action. The Economics Close.

Docket-specific, OTP-verified mass tort leads on a payment timeline that works. 30–90 day cycles. No years of carry.

0 leads delivered this week — 38 states active.

Book a Call